Research Interest: Diagnosis and management of bacterial infections in Internal Medicine, with a focus on multidrug resistance and rarer infections

Research Interest: Infectious disease diagnosis, Epidemiology of Infectious diseases, Multidrug resistant (MDR) pathogens, Laboratory markers of inflammation and infection, Diagnostic and prognostic markers associated to Infectious and chronic diseases, Laboratory quality indicators

Research Interest: Probiotics, Vaccines, Infectious Diseases, Bacteriology

Research Interest: Immune Response, Infection diseases, molecular mimicry, cancer, autoimmunity.

Research Interest: Pathophysiology and infectious disease.

Research Interest: Antibiotics, Antibiotic Resistance, Antimicrobials, MRSA ,Nosocomial Infection ,Infectious Disease Epidemiology , Infection Control, Clinical Trials Epidemiology.

Medical Degree, University of Athens, School of Medicine, Board of Internal Medicine University of Patras, School of Medicine, PhD University of Patras, School of Medicine, Board of Infectious Diseases, University of Patras, School of Medicine.

Research Interest: Infectious Diseases / sepsis

URL: http://www.med.upatras.gr/

List of Publications:

1.    Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis.

Triantos C, Kalafateli M, Assimakopoulos SF, Karaivazoglou K, Mantaka A, Aggeletopoulou I, Spantidea PI, Tsiaoussis G, Rodi M, Kranidioti H, Goukos D, Manolakopoulos S, Gogos C, Samonakis DN, Daikos GL, Mouzaki A, Thomopoulos K.Front Med (Lausanne). 2022 Mar 3;9:836306. doi: 10.3389/fmed.2022.836306. eCollection 2022.PMID: 35308545 Free PMC article.

2.    Dexamethasone in COVID-19: Should we consider a "golden hour" practice?

Akinosoglou K, Gogos C.Int J Clin Pract. 2021 Nov;75(11):e14672. doi: 10.1111/ijcp.14672.PMID: 34670346 Free PMC article. No abstract available.

3.    Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic.

Tzouvelekis A, Akinosoglou K, Karampitsakos T, Panou V, Tomos I, Tsoukalas G, Stratiki M, Dimakou K, Chrysikos S, Papaioannou O, Hillas G, Bakakos P, Stratakos G, Anagnostopoulos A, Koromilias A, Boutou A, Kioumis I, Chloros D, Kontakiotis T, Papakosta D, Papiris S, Manali E, Antonogiannaki EM, Koulouris N, Bouros D, Loukides S, Gogos C.Adv Respir Med. 2021;89(4):378-385. doi: 10.5603/ARM.a2021.0087.PMID: 34494241 Free article.

4.    Elements of Th1/Th2 response and disease severity in COVID-19 patients: A short report.

Akinosoglou K, Delastic AL, Dimakopoulou V, Marangos M, Gogos C.J Med Virol. 2022 Jan;94(1):404-406. doi: 10.1002/jmv.27313. Epub 2021 Sep 4.PMID: 34460125 Free PMC article.

5.    The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece.

Giamarellos-Bourboulis EJ, Daikos GL, Gargalianos P, Gogos C, Lazanas M, Panagopoulos P, Poulakou G, Sambatakou H, Samarkos M.Infect Dis Ther. 2021 Jun 16:1-15. doi: 10.1007/s40121-021-00471-1. Online ahead of print.PMID: 34155472

6.    Cytokine production and outcome in MDR versus non-MDR gram-negative bacteraemia and sepsis.

Karamouzos V, Giamarellos-Bourboulis EJ, Velissaris D, Gkavogianni T, Gogos C.Infect Dis (Lond). 2021 Oct;53(10):764-771. doi: 10.1080/23744235.2021.1925738. Epub 2021 Jun 17.PMID: 34137348

7.    The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece.

Giamarellos-Bourboulis EJ, Daikos GL, Gargalianos P, Gogos C, Lazanas M, Panagopoulos P, Poulakou G, Sambatakou H, Samarkos M.Infect Dis Ther. 2021 Sep;10(3):1081-1095. doi: 10.1007/s40121-021-00471-1. Epub 2021 Jun 16.PMID: 34137001 Free PMC article.

8.    Continuous positive airway pressure in the treatment of COVID-19 patients with respiratory failure. A report of six cases with excellent outcome.

Velissaris D, Aretha D, Tsiotsios K, Gogos C, Karamouzos V.Adv Respir Med. 2021;89(2):197-202. doi: 10.5603/ARM.a2020.0181. Epub 2021 Apr 19.PMID: 33871045 Free article.

9.    Coronavirus disease 2019 pandemic in Greece, February 26 - May 3, 2020: The first wave.

Maltezou HC, Papadima K, Gkolfinopoulou K, Ferentinos G, Mouratidou E, Andreopoulou A, Pavli A, Magaziotou I, Georgakopoulou T, Mellou K, Vorou R, Antoniadou A, Stathakarou A, Chrysochoou A, Gogos C, Karaiskou A, Kotanidou A, Koutsoukou A, Marangos M, Mentis A, Metallidis S, Papa A, Pefanis A, Tsakris A, Sipsas NV.Travel Med Infect Dis. 2021 May-Jun;41:102051. doi: 10.1016/j.tmaid.2021.102051. Epub 2021 Apr 2.PMID: 33819570 Free PMC article. No abstract available.

10.    Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays.

Fotis C, Meimetis N, Tsolakos N, Politou M, Akinosoglou K, Pliaka V, Minia A, Terpos E, Trougakos IP, Mentis A, Marangos M, Panayiotakopoulos G, Dimopoulos MA, Gogos C, Spyridonidis A, Alexopoulos LG.Sci Rep. 2021 Mar 23;11(1):6614. doi: 10.1038/s41598-021-86035-2.PMID: 33758278 Free PMC article.

11.    Evolution of epidemiological characteristics of infective endocarditis in Greece.

Giannitsioti E, Pefanis A, Gogos C, Lekkou A, Dalekos GN, Gatselis N, Georgiadou S, Nikou P, Vrettou A, Rigopoulos A, Tryfonopoulos C, Tsaganos T, Karofilakis E, Psarrakis C, Argyriou M, Gargalianos-Kakolyris P, Adamis G, Lourida P, Kofteridis D, Andrianaki A, Loupa C, Kostis E, Sinapidis D, Sympardi S, Alexiou N, Karaiskos I, Masgala A, Maltezos E, Panagopoulos P, Sachpekidis V, Evdoridis C, Sipsas NV, Daikos G, Giamarellou H; Hellenic Society of Chemotherapy.Int J Infect Dis. 2021 May;106:213-220. doi: 10.1016/j.ijid.2021.03.009. Epub 2021 Mar 9.PMID: 33711517 Free article.

12.    Assessment of HIV testing recommendations in Greek specialty guidelines: A missed opportunity and room for improvement for recommending testing.

Akinosoglou K, Kostaki EG, Paraskevis D, Gogos CA.AIDS Care. 2021 Oct;33(10):1312-1315. doi: 10.1080/09540121.2021.1876837. Epub 2021 Mar 7.PMID: 33678071 Review.

13.    Patterns, price and predictors of successful empiric antibiotic therapy in a real-world setting.

Akinosoglou K, Koutsouri CP, deLastic AL, Kolosaka M, Davoulos C, Niarou V, Kosmopoulou F, Ziazias D, Theodoraki S, Gogos C.J Clin Pharm Ther. 2021 Jun;46(3):846-852. doi: 10.1111/jcpt.13372. Epub 2021 Feb 7.PMID: 33554360

14.    Natural history of grade 1 ascites in patients with liver cirrhosis.

Theodorakopoulos T, Kalafateli M, Kalambokis GN, Samonakis DN, Aggeletopoulou I, Tsolias C, Mantaka A, Tselekouni P, Vourli G, Assimakopoulos SF, Gogos C, Thomopoulos K, Milionis H, Triantos C.Ann Gastroenterol. 2021;34(1):93-103. doi: 10.20524/aog.2020.0553. Epub 2020 Nov 20.PMID: 33414628 Free PMC article.

15.    Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study.

Karampitsakos T, Akinosoglou K, Papaioannou O, Panou V, Koromilias A, Bakakos P, Loukides S, Bouros D, Gogos C, Tzouvelekis A.Front Med (Lausanne). 2020 Dec 11;7:616292. doi: 10.3389/fmed.2020.616292. eCollection 2020.PMID: 33363191 Free PMC article.

16.    Patient-reported outcomes in HIV clinical trials evaluating antiretroviral treatment: a systematic review.

Akinosoglou K, Antonopoulou S, Katsarolis I, Gogos CA.AIDS Care. 2021 Sep;33(9):1118-1126. doi: 10.1080/09540121.2020.1852160. Epub 2020 Dec 3.PMID: 33267620

17.    Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.

Karaiskos I, Daikos GL, Gkoufa A, Adamis G, Stefos A, Symbardi S, Chrysos G, Filiou E, Basoulis D, Mouloudi E, Galani L, Akinosoglou K, Arvaniti K, Masgala A, Petraki M, Papadimitriou E, Galani I, Poulakou G, Routsi C, Giamarellou H; Hellenic Ceftazidime/Avibactam Registry Study Group.J Antimicrob Chemother. 2021 Feb 11;76(3):775-783. doi: 10.1093/jac/dkaa503.PMID: 33249436

18.    SARS-CoV-2 persistence and non-protective immunity in infected haematological patients.

Akinosoglou K, Paliogianni F, Spyridonidis A, Symeonidis A, Alexopoulos LG, Ziazias D, Kouraklis-Symeonidis A, Marangos M, Gogos C.Br J Haematol. 2021 Jan;192(2):e51-e54. doi: 10.1111/bjh.17212. Epub 2020 Nov 20.PMID: 33216364 Free PMC article. No abstract available.

19.    Ketamine in COVID-19 patients: Thinking out of the box.

Akinosoglou K, Gogos A, Papageorgiou C, Angelopoulos E, Gogos C.J Med Virol. 2021 Jul;93(7):4069-4070. doi: 10.1002/jmv.26681. Epub 2020 Dec 1.PMID: 33215721 Free PMC article. No abstract available.

20.    Diabetes on sepsis outcomes in non-ICU patients: A cohort study and review of the literature.

Akinosoglou K, Kapsokosta G, Mouktaroudi M, Rovina N, Kaldis V, Stefos A, Kontogiorgi M, Giamarellos-Bourboulis E, Gogos C; Hellenic Sepsis Study Group.J Diabetes Complications. 2021 Jan;35(1):107765. doi: 10.1016/j.jdiacomp.2020.107765. Epub 2020 Oct 9.PMID: 33187869 Review.

21.    Hospital factors associated with SARS-CoV-2 infection among healthcare personnel in Greece.

Maltezou HC, Dedoukou X, Tsonou P, Tseroni M, Raftopoulos V, Pavli A, Papadima K, Chrysochoou A, Randou E, Adamis G, Kostis E, Pefanis A, Gogos C, Sipsas NV.J Hosp Infect. 2021 Mar;109:40-43. doi: 10.1016/j.jhin.2020.10.010. Epub 2020 Oct 22.PMID: 33169676 Free PMC article.

22.    Evidence for increased circulating procoagulant phospholipids in patients with COVID-19 pneumonia and their prognostic role.

Assimakopoulos SF, Emmanuil A, Tsimeka A, Chalkidi T, Marangos M, Gogos C.Clin Chem Lab Med. 2020 Oct 29;59(2):e53-e55. doi: 10.1515/cclm-2020-1260.PMID: 33112778 No abstract available.

23.    A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission Clusters.

Kostaki EG, Gova M, Adamis G, Xylomenos G, Chini M, Mangafas N, Lazanas M, Metallidis S, Tsachouridou O, Papastamopoulos V, Chatzidimitriou D, Kakalou E, Antoniadou A, Papadopoulos A, Psichogiou M, Basoulis D, Pilalas D, Papageorgiou I, Paraskeva D, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Bolanos V, Sipsas NV, Lada M, Barbounakis E, Kantzilaki E, Panagopoulos P, Petrakis V, Drimis S, Gogos C, Hatzakis A, Beloukas A, Skoura L, Paraskevis D.Viruses. 2020 Oct 19;12(10):1183. doi: 10.3390/v12101183.PMID: 33086773 Free PMC article.

24.    Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern.

Akinosoglou K, Gogos C.Respirology. 2020 Nov;25(11):1209. doi: 10.1111/resp.13939. Epub 2020 Sep 20.PMID: 32954552 Free PMC article.

25.    Biomarkers in pediatric sepsis: a review of recent literature.

Z Oikonomakou M, Gkentzi D, Gogos C, Akinosoglou K.Biomark Med. 2020 Jul;14(10):895-917. doi: 10.2217/bmm-2020-0016. Epub 2020 Aug 18.PMID: 32808806 Review.

26.    Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity.

Halvatsiotis P, Kotanidou A, Tzannis K, Jahaj E, Magira E, Theodorakopoulou M, Konstandopoulou G, Gkeka E, Pourzitaki C, Kapravelos N, Papoti S, Sileli M, Gogos C, Velissaris D, Markou N, Stefanatou E, Vlachogianni G, Aimoniotou E, Komnos A, Zafeiridis T, Koulouvaris P, Armaganidis A, Bamias A, Dimopoulos G.Diabetes Res Clin Pract. 2020 Aug;166:108331. doi: 10.1016/j.diabres.2020.108331. Epub 2020 Jul 17.PMID: 32682810 Free PMC article.

27.    A cluster of COVID-19 in pilgrims to Israel.

Pavli A, Smeti P, Papadima K, Andreopoulou A, Hadjianastasiou S, Triantafillou E, Vakali A, Kefaloudi C, Pervanidou D, Gogos C, Maltezou HC.J Travel Med. 2020 Aug 20;27(5):taaa102. doi: 10.1093/jtm/taaa102.PMID: 32584403 Free PMC article. No abstract available.

28.    Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.

Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators.JAMA Netw Open. 2020 Jun 1;3(6):e2013136. doi: 10.1001/jamanetworkopen.2020.13136.PMID: 32579195 Free PMC article. Clinical Trial.

29.    Prognosis of COVID-19: Changes in laboratory parameters.

Lagadinou M, Salomou EE, Zareifopoulos N, Marangos M, Gogos C, Velissaris D.Infez Med. 2020 Jun 1;28(suppl 1):89-95.PMID: 32532944 Free article.

30.    High flow nasal cannula oxygen therapy in adults with COVID-19 respiratory failure. A case report.

Karamouzos V, Fligou F, Gogos C, Velissaris D.Monaldi Arch Chest Dis. 2020 Jun 9;90(2). doi: 10.4081/monaldi.2020.1323.PMID: 32512988 Free article.

31.    Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis.

Assimakopoulos SF, Papadopoulou I, Bantouna D, de Lastic AL, Rodi M, Mouzaki A, Gogos CA, Zolota V, Maroulis I.Shock. 2021 May 1;55(5):666-675. doi: 10.1097/SHK.0000000000001566.PMID: 32496421

32.    Remdesivir and tocilizumab: Mix or match.

Akinosoglou K, Velissaris D, Ziazias D, Davoulos C, Tousis A, Tsiotsios K, Kalogeropoulou C, Spyridonidis A, Marangos M, Fligkou F, Gogos C.J Med Virol. 2021 Jan;93(1):56-58. doi: 10.1002/jmv.26117. Epub 2020 Jun 19.PMID: 32492200 Free PMC article.

33.    Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group.

Velissaris D, Dimopoulos G, Parissis J, Alexiou Z, Antonakos N, Babalis D, Gerakari S, Kaldis V, Koutoukas P, Lada M, Leventogiannis K, Pantazopoulos I, Papadopoulos A, Polyzogopoulou E, Gogos C, Armaganidis A, Giamarellos-Bourboulis EJ.Infect Dis Ther. 2020 Sep;9(3):407-416. doi: 10.1007/s40121-020-00301-w. Epub 2020 May 12.PMID: 32399855 Free PMC article.

34.    Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.

Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami ME, Katsaounou P, Ntaganou M, Kyriakopoulou M, Dimopoulos G, Koutsodimitropoulos I, Velissaris D, Koufargyris P, Karageorgos A, Katrini K, Lekakis V, Lupse M, Kotsaki A, Renieris G, Theodoulou D, Panou V, Koukaki E, Koulouris N, Gogos C, Koutsoukou A.Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.PMID: 32320677 Free PMC article.

35.    The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design.

Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, Gargalianos P, Giamarellou H, Gogos C, Daikos G, Lazanas M, Lagiou P, Saroglou G, Sipsas N, Tsiodras S, Chatzigeorgiou D, Moussas N, Kotanidou A, Koulouris N, Oikonomou E, Kaoukis A, Kossyvakis C, Raisakis K, Fountoulaki K, Comis M, Tsiachris D, Sarri E, Theodorakis A, Martinez-Dolz L, Sanz-Sánchez J, Reimers B, Stefanini GG, Cleman M, Filippou D, Olympios CD, Pyrgakis VN, Goudevenos J, Hahalis G, Kolettis TM, Iliodromitis E, Tousoulis D, Stefanadis C.Hellenic J Cardiol. 2020 Jan-Feb;61(1):42-45. doi: 10.1016/j.hjc.2020.03.002. Epub 2020 Apr 3.PMID: 32251729 Free PMC article.

36.    Evaluation of the Activity of Neutrophils and Monocytes in Diabetic Patients With Sepsis, Can Surface Antigens HLA-DR and CD64 Be Useful as Prognostic Factors?

Lekka K, Marangos M, Roupas N, Karakantza M, Gogos C, Velissaris D.J Clin Med Res. 2020 Mar;12(3):157-164. doi: 10.14740/jocmr4068. Epub 2020 Mar 2.PMID: 32231751 Free PMC article.

37.    Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece.

Touloumi G, Kalpourtzi N, Papastamopoulos V, Paparizos V, Adamis G, Antoniadou A, Chini M, Karakosta A, Makrilakis K, Gavana M, Vantarakis A, Psichogiou M, Metallidis S, Sipsas NV, Sambatakou H, Hadjichristodoulou C, Voulgari PV, Chrysos G, Gogos C, Chlouverakis G, Tripsianis G, Alamanos Y, Stergiou G; AMACS and EMENO.PLoS One. 2020 Mar 30;15(3):e0230730. doi: 10.1371/journal.pone.0230730. eCollection 2020.PMID: 32226048 Free PMC article.

38.    Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit.

Protopapa MN, Lagadinou M, Papagiannis T, Gogos CA, Solomou EE.Case Rep Oncol Med. 2020 Feb 26;2020:7526042. doi: 10.1155/2020/7526042. eCollection 2020.PMID: 32158574 Free PMC article.

39.    The Prognostic Value of Endotoxemia and Intestinal Barrier Biomarker ZO-1 in Bacteremic Sepsis.

Assimakopoulos SF, Akinosoglou K, de Lastic AL, Skintzi A, Mouzaki A, Gogos CA.Am J Med Sci. 2020 Feb;359(2):100-107. doi: 10.1016/j.amjms.2019.10.006. Epub 2019 Oct 22.PMID: 31812215 Clinical Trial.

40.    Vitamin D-related immunomodulation in patients with liver cirrhosis.

Triantos C, Kalafateli M, Aggeletopoulou I, Diamantopoulou G, Spantidea PI, Michalaki M, Vourli G, Konstantakis C, Assimakopoulos SF, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K.Eur J Gastroenterol Hepatol. 2020 Jul;32(7):867-876. doi: 10.1097/MEG.0000000000001597.PMID: 31789949

41.    Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.

Kyriazopoulou E, Sinapidis D, Halvatzis S, Velissaris D, Alexiou N, Kosmas V, Adami ME, Kyprianou M, Kyprianou A, Stefos A, Lada M, Koutoukas P, Pavlaki M, Kyriakoudi A, Makina A, Gogos C, Niederman MS, Giamarellos-Bourboulis EJ.Int J Antimicrob Agents. 2020 Jan;55(1):105836. doi: 10.1016/j.ijantimicag.2019.10.017. Epub 2019 Nov 5.PMID: 31704213

42.    Relation Between Central Venous, Peripheral Venous and Arterial Lactate Levels in Patients With Sepsis in the Emergency Department.

Velissaris D, Karamouzos V, Pantzaris ND, Kyriakopoulou O, Gogos C, Karanikolas M.J Clin Med Res. 2019 Sep;11(9):629-634. doi: 10.14740/jocmr3897. Epub 2019 Sep 1.PMID: 31523336 Free PMC article.

43.    Microbiology of acute bacterial skin and skin-structure infections in Greece: A proposed clinical prediction score for the causative pathogen.

Nodaras C, Kotsaki A, Tziolos N, Kontopoulou T, Akinosoglou K, Chrisanthakopoulou M, Kranidioti E, Kritselis I, Voloudakis N, Vittoros V, Gogkou A, Fillas I, Toutouzas KG, Bristianou M, Tsoutsos D, Christaki E, Adamis G, Kaziani K, Tsironis C, Lada M, Kokkinakis E, Sympardi S, Koutelidakis IM, Karkamanis A, Pantazi A, Bayram C, Alexiou Z, Mousoulis G, Gogos C, O'Hare M, Griffiths D, MacGowan A, Sambatakou H, Giamarellos-Bourboulis EJ.Int J Antimicrob Agents. 2019 Dec;54(6):750-756. doi: 10.1016/j.ijantimicag.2019.08.020. Epub 2019 Aug 31.PMID: 31479742

44.    The use of soluble urokinase plasminogen activator receptor (suPAR) as a marker of sepsis in the emergency department setting. A current review.

Velissaris D, Pierrakos C, Karamouzos V, Pantzaris ND, Gogos C.Acta Clin Belg. 2021 Feb;76(1):79-84. doi: 10.1080/17843286.2019.1653519. Epub 2019 Aug 21.PMID: 31434557 Review.

45.    A Case of Serratia marcescens Endocarditis in a Nonintravenous Drug-Using Male Patient and Review of Literature.

Nikolakopoulos A, Koutsogiannis N, Xaplanteri P, Gogos C, Kolonitsiou F, Lekkou A.Case Rep Infect Dis. 2019 Jun 20;2019:3715404. doi: 10.1155/2019/3715404. eCollection 2019.PMID: 31321106 Free PMC article.

46.    Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.

Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, Adamis G, Antoniadou A, Psichogiou M, Chini M, Sambatakou H, Sipsas NV, Gogos C, Chrysos G, Panagopoulos P, Katsarou O, Gikas A, Touloumi G; AMACS.AIDS. 2019 Aug 1;33(10):1645-1655. doi: 10.1097/QAD.0000000000002248.PMID: 31305332

47.    Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study.

Assimakopoulos SF, Karamouzos V, Lefkaditi A, Sklavou C, Kolonitsiou F, Christofidou M, Fligou F, Gogos C, Marangos M.Infez Med. 2019 Mar 1;27(1):11-16.PMID: 30882373 Free article.

48.    Electroencephalographic Abnormalities in Sepsis Patients in Correlation to the Calculated Prognostic Scores: A Case Series.

Velissaris D, Pantzaris ND, Skroumpelou A, Polychronopoulos P, Karamouzos V, Pierrakos C, Gogos C, Karanikolas M.J Transl Int Med. 2018 Dec 31;6(4):176-180. doi: 10.2478/jtim-2018-0032. eCollection 2018 Dec.PMID: 30637204 Free PMC article.

49.    HIV cascade of care in Greece: Useful insights from additional stages.

Vourli G, Nikolopoulos G, Paparizos V, Skoutelis A, Metallidis S, Gargalianos P, Papadopoulos A, Chini M, Sipsas NV, Psychogiou M, Chrysos G, Sambatakou H, Gogos C, Katsarou O, Paraskeva D, Dedes N, Touloumi G; Greek HIV Prevention Group.PLoS One. 2018 Nov 15;13(11):e0207355. doi: 10.1371/journal.pone.0207355. eCollection 2018.PMID: 30440000 Free PMC article. Clinical Trial.

50.    Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis.

Triantos C, Aggeletopoulou I, Kalafateli M, Spantidea PI, Vourli G, Diamantopoulou G, Tapratzi D, Michalaki M, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K.Sci Rep. 2018 Sep 14;8(1):14065. doi: 10.1038/s41598-018-32482-3.PMID: 30218108 Free PMC article.

51.    The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort.

Pantazis N, Chini M, Antoniadou A, Sambatakou H, Skoutelis A, Gargalianos P, Kourkounti S, Gogos C, Chrysos G, Psichogiou M, Sipsas NV, Katsarou O, Panagopoulos P, Metallidis S, Touloumi G; AMACS.PLoS One. 2018 Sep 12;13(9):e0203601. doi: 10.1371/journal.pone.0203601. eCollection 2018.PMID: 30208097 Free PMC article.

52.    The Role of the Gut Barrier Function in Health and Disease.

Assimakopoulos SF, Triantos C, Maroulis I, Gogos C.Gastroenterology Res. 2018 Aug;11(4):261-263. doi: 10.14740/gr1053w. Epub 2018 Feb 8.PMID: 30116424 Free PMC article. No abstract available.

53.    Gut-origin sepsis in the critically ill patient: pathophysiology and treatment.

Assimakopoulos SF, Triantos C, Thomopoulos K, Fligou F, Maroulis I, Marangos M, Gogos CA.Infection. 2018 Dec;46(6):751-760. doi: 10.1007/s15010-018-1178-5. Epub 2018 Jul 12.PMID: 30003491

54.    Muscle fat infiltration assessed by total psoas density on computed tomography predicts mortality in cirrhosis.

Kalafateli M, Karatzas A, Tsiaoussis G, Koutroumpakis E, Tselekouni P, Koukias N, Konstantakis C, Assimakopoulos S, Gogos C, Thomopoulos K, Kalogeropoulou C, Triantos C.Ann Gastroenterol. 2018 Jul-Aug;31(4):491-498. doi: 10.20524/aog.2018.0256. Epub 2018 Apr 4.PMID: 29991895 Free PMC article.

55.    Propranolol reduces systemic oxidative stress and endotoxemia in cirrhotic patients with esophageal varices.

Taprantzi D, Zisimopoulos D, Thomopoulos KC, Spiliopoulou I, Georgiou CD, Tsiaoussis G, Triantos C, Gogos CA, Labropoulou-Karatza C, Assimakopoulos SF.Ann Gastroenterol. 2018 Mar-Apr;31(2):224-230. doi: 10.20524/aog.2017.0222. Epub 2017 Dec 22.PMID: 29507470 Free PMC article.

56.    Correlation between neutrophil-to-lymphocyte ratio and severity scores in septic patients upon hospital admission. A series of 50 patients.

Velissaris D, Pantzaris ND, Bountouris P, Gogos C.Rom J Intern Med. 2018 Sep 1;56(3):153-157. doi: 10.2478/rjim-2018-0005.PMID: 29427556 Free article.

57.    Reduced circulating B cells and plasma IgM levels are associated with decreased survival in sepsis - A meta-analysis.

Krautz C, Maier SL, Brunner M, Langheinrich M, Giamarellos-Bourboulis EJ, Gogos C, Armaganidis A, Kunath F, Grützmann R, Weber GF.J Crit Care. 2018 Jun;45:71-75. doi: 10.1016/j.jcrc.2018.01.013. Epub 2018 Feb 14.PMID: 29413726

58.    Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.

Papst L, Beović B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M; ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group.Clin Microbiol Infect. 2018 Oct;24(10):1070-1076. doi: 10.1016/j.cmi.2018.01.015. Epub 2018 Feb 1.PMID: 29410094 Free article.

59.    How well does qSOFA correspond to underlying systemic inflammatory response?

Akinosoglou K, Theodoraki S, Gkavogianni T, Pistiki A, Giamarellos-Bourboulis E, Gogos CA.Cytokine. 2018 Oct;110:288-290. doi: 10.1016/j.cyto.2018.01.019. Epub 2018 Feb 1.PMID: 29396053

60.    Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor-Activator Target Sequence of 5'-LTR.

Panagoulias I, Karagiannis F, Aggeletopoulou I, Georgakopoulos T, Argyropoulos CP, Akinosoglou K, Gogos C, Skoutelis A, Mouzaki A.Front Immunol. 2018 Jan 4;8:1924. doi: 10.3389/fimmu.2017.01924. eCollection 2017.PMID: 29354130 Free PMC article.

61.    Renal vein thrombosis complicating severe acute pyelonephritis with renal abscesses and associated bacteraemia caused by extended-spectrum beta-lactamase producing Escherichia coli.

Assimakopoulos SF, Kraniotis P, Gogos C, Marangos M.CEN Case Rep. 2018 May;7(1):90-93. doi: 10.1007/s13730-017-0301-2. Epub 2018 Jan 11.PMID: 29327131 Free PMC article.

62.    Acute Abdominal Pain Assessment in the Emergency Department: The Experience of a Greek University Hospital.

Velissaris D, Karanikolas M, Pantzaris N, Kipourgos G, Bampalis V, Karanikola K, Fafliora E, Apostolopoulou C, Gogos C.J Clin Med Res. 2017 Dec;9(12):987-993. doi: 10.14740/jocmr3206w. Epub 2017 Nov 6.PMID: 29163731 Free PMC article.

63.    Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas.

Delivanis DA, Iñiguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, Thomas MA, Gogos C, Young WF, Bancos I, Kyriazopoulou V.Clin Endocrinol (Oxf). 2018 Feb;88(2):209-216. doi: 10.1111/cen.13512. Epub 2017 Nov 29.PMID: 29115003

64.    Procalcitonin as a diagnostic and prognostic marker in diabetic foot infection. A current literature review.

Velissaris D, Pantzaris ND, Platanaki C, Antonopoulou N, Gogos C.Rom J Intern Med. 2018 Mar 1;56(1):3-8. doi: 10.1515/rjim-2017-0039.PMID: 29028632 Free article. Review.

65.    Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.

Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, Gill J, Vandenhende MA, Barger D, Lodi S, Moreno S, Arribas JR, Pacheco A, Cardoso SW, Chrysos G, Gogos C, Abgrall S, Costagliola D, Meyer L, Seng R, van Sighem A, Reiss P, Muga R, Hoyos SP, Braun D, Hauser C, Barrufet P, Leyes M, Tate J, Justice A, Hernán MA.J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):102-109. doi: 10.1097/QAI.0000000000001562.PMID: 28991888 Free PMC article.

66.    Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis.

Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, Dimopoulos G, Pantazi A, Orfanos SE, Rovina N, Tsangaris I, Gkavogianni T, Botsa E, Chassiou E, Kotanidou A, Kontouli C, Chaloulis P, Velissaris D, Savva A, Cullberg JS, Akinosoglou K, Gogos C, Armaganidis A, Giamarellos-Bourboulis EJ; Hellenic Sepsis Study Group.BMC Med. 2017 Sep 18;15(1):172. doi: 10.1186/s12916-017-0930-5.PMID: 28918754 Free PMC article. Clinical Trial.

67.    Sepsis-3 in Community-acquired Pneumonia: How Reliable Is It?

Akinosoglou K, Gogos C.Am J Respir Crit Care Med. 2018 Feb 15;197(4):537. doi: 10.1164/rccm.201707-1414LE.PMID: 28891672 No abstract available.

68.    Platelet reactivity in sepsis syndrome: results from the PRESS study.

Akinosoglou K, Theodoraki S, Xanthopoulou I, Perperis A, Gkavogianni T, Pistiki A, Giamarellos-Bourboulis E, Gogos CA.Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2503-2512. doi: 10.1007/s10096-017-3093-6. Epub 2017 Aug 24.PMID: 28840345

69.    Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.

Skoutelis A, Pefanis A, Tsiodras S, Sipsas NV, Lelekis M, Lazanas MC, Gargalianos P, Dalekos GN, Roilides E, Samonis G, Maltezos E, Hatzigeorgiou D, Lada M, Metallidis S, Stoupis A, Chrysos G, Karnesis L, Symbardi S, Loupa CV, Giamarellou H, Kioumis I, Sambatakou H, Tsianos E, Kotsopoulou M, Georgopali A, Liakou K, Perlorentzou S, Levidiotou S, Giotsa-Toutouza M, Tsorlini-Christoforidou H, Karaiskos I, Kouppari G, Trikka-Graphakos E, Ntrivala MA, Themeli-Digalaki K, Pangalis A, Kachrimanidou M, Martsoukou M, Karapsias S, Panopoulou M, Maraki S, Orfanou A, Petinaki E, Orfanidou M, Baka V, Stylianakis A, Spiliopoulou I, Smilakou S, Zerva L, Vogiatzakis E, Belesiotou E, Gogos CA.PLoS One. 2017 Aug 16;12(8):e0182799. doi: 10.1371/journal.pone.0182799. eCollection 2017.PMID: 28813492 Free PMC article.

70.    Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, Gogos CA, Pantazis N, Dabis F, Vandenhende MA, Meyer L, Seng R, Gill MJ, Krentz H, Phillips AN, Porter K, Grinsztejn B, Pacheco AG, Muga R, Tate J, Justice A, Hernán MA.J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):311-318. doi: 10.1097/QAI.0000000000001498.PMID: 28746165 Free PMC article.

71.    Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.

Triantos C, Kalafateli M, Aggeletopoulou I, Mandellou M, Assimakopoulos S, Tselekouni P, Taprantzi D, Tsiaoussis G, Vourli G, Anastassiou ED, Gogos C, Labropoulou-Karatza C, Thomopoulos K.Eur J Gastroenterol Hepatol. 2017 Sep;29(9):998-1003. doi: 10.1097/MEG.0000000000000924.PMID: 28746158

72.    Diagnosis of neurobrucellosis in resource-limited real-world settings: A case-series of 8 patients.

Despotopoulos S, Akinosoglou K, Tzimas T, Akritidis N, Gogos C.J Neurol Sci. 2017 Aug 15;379:293-295. doi: 10.1016/j.jns.2017.06.024. Epub 2017 Jun 16.PMID: 28716264 No abstract available.

73.    Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study.

Triantos C, Kalafateli M, Spantidea PI, Goukos D, Koutroumpakis E, Konstantakis C, Assimakopoulos SF, Gogos C, Mouzaki A, Daikos G, Thomopoulos K.Ann Gastroenterol. 2017;30(4):450-456. doi: 10.20524/aog.2017.0142. Epub 2017 Apr 6.PMID: 28655984 Free PMC article.

74.    Sepsis favors high-on-clopidogrel platelet reactivity.

Akinosoglou K, Perperis A, Theodoraki S, Alexopoulos D, Gogos C.Platelets. 2018 Jan;29(1):76-78. doi: 10.1080/09537104.2017.1319919. Epub 2017 Jun 21.PMID: 28635374

75.    Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction.

Ioakeimidou A, Pagalou E, Kontogiorgi M, Antoniadou E, Kaziani K, Psaroulis K, Giamarellos-Bourboulis EJ, Prekates A, Antonakos N, Lassale P, Gogos C; Hellenic Sepsis Study Group.Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1749-1756. doi: 10.1007/s10096-017-2988-6. Epub 2017 Apr 28.PMID: 28455780 Free PMC article.

76.    Pleural empyema due to Salmonella enterica serovar Enteritidis in an immunocompetent elderly patient: a case report.

Xaplanteri P, Assimakopoulos SF, Karachalios K, Siagris D, Lekkou A, Anastassiou ED, Spiliopoulou I, Gogos C, Kolonitsiou F.JMM Case Rep. 2016 Aug 30;3(4):e005051. doi: 10.1099/jmmcr.0.005051. eCollection 2016 Aug.PMID: 28348773 Free PMC article.

77.    Anti-Xa activity in patients with hepatocellular carcinoma.

Triantos C, Emmanuil A, Aggeletopoulou I, Tsolias C, Grigoropoulou X, Jelastopulu E, Koukias N, Assimakopoulos S, Gogos C, Labropoulou-Karatza C, Thomopoulos K.J Gastrointestin Liver Dis. 2017 Mar;26(1):91-92. doi: 10.15403/jgld.2014.1121.261.axa.PMID: 28338119 Free article. No abstract available.

78.    Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.

Kalafateli M, Zisimopoulos K, Vourli G, Rigamonti C, Goulis J, Manesis E, Manolakopoulos S, Tsochatzis E, Georgiou A, Diamantopoulou G, Thomopoulos K, Gogos C, Touloumi G, Akriviadis E, Lambropoulou-Karatza C, Triantos C.Dig Dis Sci. 2017 May;62(5):1363-1372. doi: 10.1007/s10620-017-4504-3. Epub 2017 Mar 1.PMID: 28251503 Free article.

79.    36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.

Skype ID: Lambis.gogos1

Research Interest: IBD en viruses, Infectious Gastro-Enteritis, Esophageal fungal infections

Dr. Banikalyan Swain obtained his Ph.D. in Biotechnology from Utkal University in 2015, Bhubaneswar, India. He joined University of Florida as a Postdoctoral Associate in 2015. Currently he is working as a Research Scientist in Department of Infectious Diseases and Immunology, University of Florida. Dr. Swain focused on innate and adaptive immune mechanism of fish and he has published his research in different reputed peer reviewed journals. He is working on the design, construction and evaluation of genetically modified derivatives of Edwardsiella piscicida, as vaccine vectors to deliver protective antigens encoded by genes from other pathogens as well as DNA vaccines encoding such protective antigens. Dr. Swain and his group has designed a regulated delayed attenuation and programmed self-destructing Edwardsiella piscicida strains that efficiently colonize fish lymphoid tissues, allow release of the bacterial cell contents after lysis and exhibit complete biological containment. These technologies are being used to reduce morbidity and mortality caused by bacterial, viral and parasite infectious disease agents of fish.

Research Interest: Bacterial pathogenesis, Host-pathogen interactions, Innate and adaptive immunity, Vaccine development

Grants:

1    Development Of Edwardsiella piscicida vaccine vector systems to prevent bacterial diseases in aquaculture”

Role: Principal Investigator

Funding: CVM 2020-21 Fall Research Grant Competition

2   Edwardsiella piscicida DNA vaccine vector to prevent infection by Tilapia Lake Virus (TiLV) as a model vaccine to develop a generalized vaccine vector to protect commercial fish from multiple infectious diseases to improve aquaculture productivity

Role: Key Personnel

Funding: FOUNDATION FOR FOOD AND AGRICULTURE RES

3    Edwardsiella piscicida: a vaccine delivery platform for multiple fish pathogens

Role: Key Personnel. Funding: USDA/NIFA Animal Health.

List of Publications:

Research articles (Peer-reviewed)
1.    Swain B, Powell CT, Curtiss R. Construction and evaluation of Recombinant Attenuated Edwardsiella piscicida Vaccine (RAEV) vector system encoding Ichthyophthirius multifiliis (Ich) antigen IAG52B. Journal: Journal: Frontiers in Immunology, section Microbial Immunology. Date accepted: 12/21/2021.
2.    B. Swain, C.T. Powell, R. Curtiss, Virulence, immunogenicity and live vaccine potential of aroA and phoP mutants of Edwardsiella piscicida in zebrafish, Microbial Pathogenesis 162 (2022) 105355.
3.    Swain B, Powell CT, Curtiss R. Pathogenicity and immunogenicity of Edwardsiella piscicida ferric uptake regulator (fur) mutations in zebrafish. Fish & shellfish immunology. 2020;107:497-510.
4.    Samanta M, Basu M, Swain B, Paichha M, Lenka SS, Das S, et al. Molecular cloning and characterization of LrTLR4, analysis of its inductive expression and associated down-stream signaling molecules following lipopolysaccharide stimulation and Gram-negative bacterial infection. Fish & shellfish immunology. 2017;60:164-76.
5.    Basu M, Lenka SS, Paichha M, Swain B, Patel B, Banerjee R, et al. Immunoglobulin (Ig) D in Labeo rohita is widely expressed and differentially modulated in viral, bacterial and parasitic antigenic challenges. Veterinary immunology and immunopathology. 2016;179:77-84.
6.    Swain B, Basu M, Lenka SS, Das S, Jayasankar P, Samanta M. Characterization and Inductive Expression Analysis of Interferon Gamma-Related Gene in the Indian Major Carp, Rohu (Labeo rohita). DNA and cell biology. 2015;34(5):367-78.
7.    Basu M, Paichha M, Swain B, Lenka SS, Singh S, Chakrabarti R, et al. Modulation of TLR2, TLR4, TLR5, NOD1 and NOD2 receptor gene expressions and their downstream signaling molecules following thermal stress in the Indian major carp catla (Catla catla). 3 Biotech. 2015;5(6):1021-30.
8.    Samanta M, Swain B, Basu M, Mahapatra G, Sahoo BR, Paichha M, et al. Toll-like receptor 22 in Labeo rohita: molecular cloning, characterization, 3D modeling, and expression analysis following ligands stimulation and bacterial infection. Applied biochemistry and biotechnology. 2014;174(1):309-27.
9.    Bej A, Sahoo BR, Swain B, Basu M, Jayasankar P, Samanta M. LRRsearch: An asynchronous server-based application for the prediction of leucine-rich repeat motifs and an integrative database of NOD-like receptors. Computers in biology and medicine. 2014;53:164-70.
10.    Samanta M, Basu M, Swain B, Panda P, Jayasankar P. Molecular cloning and characterization of Toll-like receptor 3, and inductive expression analysis of type I IFN, Mx and pro-inflammatory cytokines in the Indian carp, rohu (Labeo rohita). Molecular biology reports. 2013;40(1):225-35.
11.    Swain B, Basu M, Samanta M. NOD1 and NOD2 receptors in mrigal (Cirrhinus mrigala): inductive expression and downstream signalling in ligand stimulation and bacterial infections. Journal of biosciences. 2013;38(3):533-48.
12.    Sahoo BR, Swain B, Dikhit MR, Basu M, Bej A, Jayasankar P, et al. Activation of nucleotide-binding oligomerization domain 1 (NOD1) receptor signaling in Labeo rohita by iE-DAP and identification of ligand-binding key motifs in NOD1 by molecular modeling and docking. Applied biochemistry and biotechnology. 2013;170(6):1282-309.
13.    Sahoo BR, Basu M, Swain B, Dikhit MR, Jayasankar P, Samanta M. Elucidation of novel structural scaffold in rohu TLR2 and its binding site analysis with peptidoglycan, lipoteichoic acid and zymosan ligands, and downstream MyD88 adaptor protein. BioMed research international. 2013:185282.
14.    Maharana J, Swain B, Sahoo BR, Dikhit MR, Basu M, Mahapatra AS, et al. Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita. Fish physiology and biochemistry. 2013;39(4):1007-23.
15.    Swain B, Maiti NK, Samanta M. Nucleotide Binding and Oligomerization Domain 1 (NOD1) Receptor in Catla (Catla catla) : Inductive Expression and Down-Stream Signaling in Ligand Stimulation and Bacterial Infections. International Research Journal of Biological Sciences. 2013;2(3):6.
16.    Basu M, Swain B, Maiti NK, Routray P, Samanta M. Inductive expression of toll-like receptor 5 (TLR5) and associated downstream signaling molecules following ligand exposure and bacterial infection in the Indian major carp, mrigal (Cirrhinus mrigala). Fish & shellfish immunology. 2012;32(1):121-31.
17.    Samanta M, Swain B, Basu M, Panda P, Mohapatra GB, Sahoo BR, et al. Molecular characterization of toll-like receptor 2 (TLR2), analysis of its inductive expression and associated down-stream signaling molecules following ligands exposure and bacterial infection in the Indian major carp, rohu (Labeo rohita). Fish & shellfish immunology. 2012;32(3):411-25.
18.    Basu M, Swain B, Sahoo BR, Maiti NK, Samanta M. Induction of toll-like receptor (TLR) 2, and MyD88-dependent TLR- signaling in response to ligand stimulation and bacterial infections in the Indian major carp, mrigal (Cirrhinus mrigala). Molecular biology reports. 2012;39(5):6015-28.
19.    Swain B, Basu M, Samanta M. Molecular cloning and characterization of nucleotide binding and oligomerization domain-1 (NOD1) receptor in the Indian Major Carp, rohu (Labeo rohita), and analysis of its inductive expression and down-stream signalling molecules following ligands exposure and Gram-negative bacterial infections. Fish & shellfish immunology. 2012;32(5):899-908.
20.    Swain B, Basu M, Sahoo BR, Maiti NK, Routray P, Eknath AE, et al. Molecular characterization of nucleotide binding and oligomerization domain (NOD)-2, analysis of its inductive expression and down-stream signaling following ligands exposure and bacterial infection in rohu (Labeo rohita). Developmental and comparative immunology. 2012;36(1):93-103.
21.    Swain B, Samanta M, Basu M, Panda P, Sahoo BR, Maiti NK, et al. Molecular characterization, inductive expression and mechanism of interleukin-10 gene induction in the Indian major carp, catla (Catla catla). Aquaculture Research. 2012;43(6):897-907.
22.    Sahoo BR, Basu M, Swain B, Maharana J, Dikhit MR, Jayasankar P, et al. Structural insights of rohu TLR3, its binding site analysis with fish reovirus dsRNA, poly I:C and zebrafish TRIF. International journal of biological macromolecules. 2012;51(4):531-43.
23.    Sahoo BR, Swain B, Basu M, Panda P, Maiti NK, Samanta M. 3D modeling and molecular dynamics simulation of an immune-regulatory cytokine, interleukin-10, from the Indian major carp, Catla catla. Journal of molecular modeling. 2012;18(5):1713-22.
24.    Swain B, Basu M, Samanta M. Cloning of interleukin-10 gene in the Indian major carp, Labeo rohita (Hamilton 1822) and its functional characterization following Aeromonas hydrophila infection. Indian Journal of Fisheries. 2011;58:39-47.

URL: ‪Banikalyan Swain - ‪Google Scholar<!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-fareast-language:EN-US;} </style>

Research Interest: Oncology, Infectious Diseases, Pharmacy, Drug Development, New Drug Discovery.

Research Interest: Clinical interests: Immunology, Infectious diseases, antimicrobial resistance, Metabolic disease, lipids, inflammation, HIV, immunocompromised hosts

Research Interest: Myelodysplastic Syndromes, Hematological Malignancies,Lymphoma,Multiple Myeloma,Hematologic Diseases,CML,Clinical Hematology,CLL,Hodgkin's Lymphoma, Blood Disorders,Acute Myeloid Leukemia,

Acute Leukemia,Acute Lymphoblastic Leukemia,Non-Hodgkin, Lymphoma,Chemotherapy,Lymphoproliferative Disorders, Chronic Myeloproliferative Neoplasms,Myelodysplastic,Myeloproliferative, Diseases, Myeloma, Neutropenia, 

 Anemia, Chronic Lymphocytic Leukemia, Diffuse Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Hematologic Neoplasms, Leukemia, Marginal Zone Lymphoma, 

Research Interest: Lactococcus lactis,  Yeast,  Flu Vaccine,  Avian Influenza Virus, Baculovirus Express System,  Astrovirus, Cancer Vaccine

Research Interest: Develop a Novel Procedure for Influenza virus subtyping and Genetic characterization from animal swabls/enviromental samples

Research Interest: Parasitology; parasitic diseases; zoonotic; epidemiology; vector-borne diseases